Form 4: SeaStar Medical Holding Corp: Chief Medical Officer Increases Stake

Kevin Chung, Chief Medical Officer of SeaStar Medical Holding Corp, recently purchased 1,000 shares of common stock at a price of $4.2581 per share.

Summary

• On September 30, 2024, Kevin Chung, the Chief Medical Officer of SeaStar Medical Holding Corp, purchased 1,000 shares of the company's common stock.
• The purchase price was $4.2581 per share.
• Following the transaction, Mr. Chung directly owns 9,435 shares of SeaStar Medical Holding Corp.
• All amounts of securities reported in this Form 4 have been adjusted to reflect the 1-for-25 reverse split effectuated by the Issuer on June 7, 2024.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to insider buying, which suggests confidence in the company's prospects. However, it's a single transaction and needs to be considered in the context of overall company performance.

Positives

• The Chief Medical Officer's purchase of shares may signal confidence in the company's future prospects.

Industry Context

Insider buying is often seen as a positive sign, suggesting that those with the most knowledge of the company's prospects are optimistic about its future.

Stakeholder Impact

• The purchase could positively influence shareholder sentiment.

Key Dates

Keywords

SeaStar Medical Holding Corp, insider trading, Form 4, Kevin Chung, stock purchase, Chief Medical Officer, ICU